USPH - U.S. Physical Therapy, Inc.
NYSE
->
Healthcare
->
Medical Care Facilities
Houston,
United States
Type: Equity
USPH price evolution
USPH
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 1 May 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $152.82 | $147.69 | $160.74 | $32.6 |
| Short term investments | ||||
| Net receivables | $69.72 | $71.43 | $71.14 | $74.46 |
| Inventory | ||||
| Total current assets | $233.38 | $228.5 | $241.8 | $117.79 |
| Long term investments | $12.26 | $12.26 | $12.23 | $12.16 |
| Property, plant & equipment | $129.53 | $128.73 | $126.56 | $125.24 |
| Goodwill & intangible assets | $619.25 | $635.02 | $614.29 | $610.34 |
| Total noncurrent assets | $763.86 | $781.69 | $757.78 | $750.33 |
| Total investments | $12.26 | $12.26 | $12.23 | $12.16 |
| Total assets | $997.24 | $1010.19 | $999.58 | $868.13 |
| Current liabilities | ||||
| Accounts payable | $3.9 | $4.51 | $3.67 | $4.23 |
| Deferred revenue | ||||
| Short long term debt | $42.94 | $42 | $38.8 | $41.38 |
| Total current liabilities | $102.19 | $82.36 | $85.82 | $90.83 |
| Long term debt | $215.64 | $218.38 | $222.37 | $258.14 |
| Total noncurrent liabilities | $242.81 | $259.63 | $258.25 | $293.54 |
| Total debt | $258.59 | $260.38 | $261.18 | $299.52 |
| Total liabilities | $345 | $341.98 | $344.07 | $384.37 |
| Shareholders' equity | ||||
| Retained earnings | $223.77 | $238.56 | $237.66 | $234.76 |
| Other shareholder equity | $2.78 | $5.75 | $4.8 | $2.65 |
| Total shareholder equity | $476.19 | $491.97 | $488.5 | $318.06 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $152.82 | $31.59 | $28.57 | $32.92 |
| Short term investments | ||||
| Net receivables | $69.72 | $69.31 | $62.42 | $50.95 |
| Inventory | ||||
| Total current assets | $233.38 | $111.27 | $95.17 | $87.64 |
| Long term investments | $12.26 | $12.13 | $12.21 | |
| Property, plant & equipment | $129.53 | $127.75 | $119.41 | $103.26 |
| Goodwill & intangible assets | $619.25 | $602.86 | $521.06 | $401.93 |
| Total noncurrent assets | $763.86 | $746.89 | $654.26 | $506.73 |
| Total investments | $12.26 | $12.13 | $12.21 | |
| Total assets | $997.24 | $858.15 | $749.43 | $594.36 |
| Current liabilities | ||||
| Accounts payable | $3.9 | $6.5 | $6.47 | $1.33 |
| Deferred revenue | ||||
| Short long term debt | $42.94 | $41.57 | $31.3 | $32.41 |
| Total current liabilities | $102.19 | $85.49 | $83.48 | $93.49 |
| Long term debt | $215.64 | $175.83 | $191.77 | $78.58 |
| Total noncurrent liabilities | $242.81 | $288.1 | $213.5 | $90.9 |
| Total debt | $258.59 | $295.34 | $223.08 | $110.99 |
| Total liabilities | $345 | $542.36 | $296.98 | $184.39 |
| Shareholders' equity | ||||
| Retained earnings | $223.77 | $232.95 | $224.4 | $212.01 |
| Other shareholder equity | $2.78 | $4 | ||
| Total shareholder equity | $476.19 | $315.79 | $295.61 | $276.16 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 1 May 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $154.8 | $150.01 | $151.49 | |
| Cost of revenue | $124.28 | $122.08 | $119.28 | |
| Gross Profit | $30.52 | $27.93 | $32.21 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $13.9 | $12.05 | $12.14 | |
| Total operating expenses | $31.4 | $12.05 | $12.14 | |
| Operating income | -$0.88 | $15.88 | $20.06 | |
| Income from continuing operations | ||||
| EBIT | $4.07 | $14.91 | $17.78 | |
| Income tax expense | $1.4 | $3.56 | $4.23 | |
| Interest expense | $2.01 | $2.1 | $2.63 | |
| Net income | ||||
| Net income | $0.66 | $9.25 | $10.92 | |
| Income (for common shares) | $0.66 | $9.25 | $10.92 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $604.8 | $553.14 | $495.02 | $422.97 |
| Cost of revenue | $483.29 | $441.12 | $377.84 | $328.52 |
| Gross Profit | $121.51 | $112.02 | $117.18 | $94.45 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $51.95 | $46.11 | $46.53 | $42.04 |
| Total operating expenses | $69.45 | $55.22 | $46.53 | $42.04 |
| Operating income | $52.06 | $56.8 | $70.65 | $52.41 |
| Income from continuing operations | ||||
| EBIT | $49.7 | $50.1 | $57.05 | $49.85 |
| Income tax expense | $12.16 | $12.16 | $15.27 | $13.02 |
| Interest expense | $9.3 | $5.78 | $0.94 | $1.63 |
| Net income | ||||
| Net income | $28.24 | $32.16 | $40.83 | $35.19 |
| Income (for common shares) | $28.24 | $32.16 | $40.83 | $35.19 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $0.66 | $9.25 | $10.92 | $7.41 |
| Operating activities | ||||
| Depreciation | $4.11 | $3.97 | $3.83 | $3.79 |
| Business acquisitions & disposals | -$6.51 | -$14.38 | -$4.52 | -$10.62 |
| Stock-based compensation | $1.78 | $1.86 | $1.79 | $1.81 |
| Total cash flows from operations | $26.84 | $16.36 | $27.43 | $11.35 |
| Investing activities | ||||
| Capital expenditures | -$2.22 | -$2.56 | -$2.46 | -$2.06 |
| Investments | ||||
| Total cash flows from investing | -$8.41 | -$16.94 | -$6.98 | -$12.68 |
| Financing activities | ||||
| Dividends paid | -$6.45 | -$6.45 | -$11.24 | |
| Sale and purchase of stock | -$0.01 | $163.66 | ||
| Net borrowings | -$2.46 | -$2.73 | -$39.6 | $5.64 |
| Total cash flows from financing | -$13.28 | -$12.48 | $107.68 | $2.34 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $5.14 | -$13.05 | $128.13 | $1.01 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $28.24 | $32.16 | $40.83 | $35.19 |
| Operating activities | ||||
| Depreciation | $15.7 | $14.74 | $11.59 | $10.53 |
| Business acquisitions & disposals | -$36.04 | -$73.39 | -$115.94 | -$43.56 |
| Stock-based compensation | $7.24 | $7.26 | $7.87 | $7.92 |
| Total cash flows from operations | $81.98 | $58.54 | $76.41 | $100 |
| Investing activities | ||||
| Capital expenditures | -$9.29 | -$7.88 | -$8.2 | -$7.64 |
| Investments | ||||
| Total cash flows from investing | -$45.02 | -$81.27 | -$124.14 | -$51.2 |
| Financing activities | ||||
| Dividends paid | -$24.13 | -$21.32 | -$18.77 | -$4.11 |
| Sale and purchase of stock | $163.65 | |||
| Net borrowings | -$39.15 | $62.42 | $79.05 | -$31.04 |
| Total cash flows from financing | $84.27 | $25.76 | $43.38 | -$39.42 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $121.23 | $3.03 | -$4.35 | $9.37 |
News
Fundamentals
| Market cap | $1.59B |
|---|---|
| Enterprise value | $1.70B |
| Shares outstanding | 14.99M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | 9.65% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 3.37 |
| Book/Share | 31.59 |
| Cash/Share | 10.20 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.72 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.28 |
| Quick ratio | 2.28 |